17:52 GMT18 January 2021
Listen Live
    Get short URL

    MOSCOW (Sputnik) - Anna Popova, the head of Russian public health watchdog Rospotrebnadzor, hopes that Phase 3 of trial of EpiVacCorona, Russia's second registered vaccine against COVID-19, will begin soon.

    "I hope the third phase will begin in a week," she said in an interview with the Rossiya 1 broadcaster.

    According to Popova, all results that have been up to this point were very good, the safety of the vaccine has been proven, and it is also areactogenic, since there is no xenogenic protein in it.

    Participants in the trials felt neither an increase in temperature nor any deterioration in health, Popova claimed.

    trial, COVID-19, Russia, vaccine
    Community standardsDiscussion